Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair Church

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Molecular Sciences|December 11, 2022
Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear PalsyFabio A Simoes, Greig Joilin, Oliver Peters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2024
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal SyndromeDavid P Vaughan, Riona Fumi, Marte Theilmann Jensen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2026
Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear PalsyLouise-Kristine Nielsen, Joshua L I Frost, David P Vaughan, et al.
Brain : a Journal of Neurology|March 28, 2023
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trialsDuncan Street, Edwin Jabbari, Alyssa Costantini, et al.
JAMA Neurology|December 21, 2019
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal SyndromeEdwin Jabbari, Negin Holland, Viorica Chelban, et al.
The Lancet. Neurology|June 20, 2025
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort studyChristina D Orrú, David P Vaughan, Nirosen Vijiaratnam, et al.
Nature Biotechnology|May 2, 2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's diseaseRoger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman, et al.
Brain : a Journal of Neurology|July 29, 2022
Neurofilament light levels predict clinical progression and death in multiple system atrophyViorica Chelban, Elham Nikram, Alexandra Perez-Soriano, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Molecular Sciences|December 11, 2022
Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear PalsyFabio A Simoes, Greig Joilin, Oliver Peters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2024
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal SyndromeDavid P Vaughan, Riona Fumi, Marte Theilmann Jensen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2026
Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear PalsyLouise-Kristine Nielsen, Joshua L I Frost, David P Vaughan, et al.
Brain : a Journal of Neurology|March 28, 2023
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trialsDuncan Street, Edwin Jabbari, Alyssa Costantini, et al.
JAMA Neurology|December 21, 2019
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal SyndromeEdwin Jabbari, Negin Holland, Viorica Chelban, et al.
The Lancet. Neurology|June 20, 2025
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort studyChristina D Orrú, David P Vaughan, Nirosen Vijiaratnam, et al.
Nature Biotechnology|May 2, 2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's diseaseRoger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman, et al.
Brain : a Journal of Neurology|July 29, 2022
Neurofilament light levels predict clinical progression and death in multiple system atrophyViorica Chelban, Elham Nikram, Alexandra Perez-Soriano, et al.
Pageof 2